dual glp-1/gip receptor agonists GIP/GLP-1 agonists: New advances for treating type-2 diabetes New consensus from multiple societies

By utilizing this multi-receptor agonist, researchers can explore complex pathways in glucose-dependent insulin secretion, energy expenditure, and lipid metabolism

The value of GSH and nutritional strategies like amino acids, vitamins, minerals, phytochemicals, sulforaphane to enhance cellular Nrf2, and other supplements used to restore GSH levels (327330) as adjunct treatments for all inflammatory diseases including SARS-CoV-2 infection needs to be further emphasized

One unit on a 1 ml (100-unit) insulin syringe equals 0.5 mg of Epithalon

Lyophilized Freeze-dried

[ Links ] Pozzi L, Invernizzi R, Garavaglia C, Samanin R (1999) Fluoxetine increases extracellular dopamine in the prefrontal cortex by a mechanism not dependent on serotonin: a comparison with citalopram